Stuart Naylor Net Worth

Stuart Naylor biography

Dr. Stuart Naylor, Ph.D. is Chief Development Officer of the Company. From April 2015 to April 2016, Dr. Naylor was Chief Executive Officer of Athena Vision Limited, a biotechnology company. From June 2013 to April 2015, Dr. Naylor served as managing director of Coltivare Ltd., a healthcare consulting company. From 2008 to 2013, Dr. Naylor was Executive Director and Chief Scientific Officer of Oxford BioMedica plc, a gene therapy company. Prior to joining Oxford BioMedica plc, Dr. Naylor focused on translational cancer research at the Institute of Cancer Research in London. Dr. Naylor has a B.S.C. in microbiology and virology from the University of Warwick, an M.S. in Immunology from Kings College London, and a Ph.D. from the Imperial Cancer Research Fund laboratory studying ovarian cancer and cytokine biology.

What is the salary of Stuart Naylor?

As the Chief Development Officer of MeiraGTx Plc, the total compensation of Stuart Naylor at MeiraGTx Plc is $838,014. There are 2 executives at MeiraGTx Plc getting paid more, with Alexandria Forbes having the highest compensation of $1,122,170.

How old is Stuart Naylor?

Stuart Naylor is 55, he’s been the Chief Development Officer of MeiraGTx Plc since 2019. There are 6 older and 4 younger executives at MeiraGTx Plc. The oldest executive at MeiraGTx Holdings Plc is Arnold Levine, 78, who is the Independent Director.

What’s Stuart Naylor’s mailing address?

Stuart’s mailing address filed with the SEC is 430 E. 29TH STREET, 10TH FLOOR, , NEW YORK, NY, 10016.

Insider trading at MeiraGTx Plc

Over the last few years, insiders at MeiraGTx Plc have traded over $0 worth of MeiraGTx Plc stock and bought 3,113,212 units worth $48,763,809 . The most active insider traders include Advisors Llcperceptive Life…, Life Sciences Master Fund L…, and Joel S Marcus. On average, MeiraGTx Plc executives and independent directors trade stock every 143 days with the average trade being worth of $15,182,092. The most recent stock trade was executed by Advisors Llcperceptive Life… on 12 August 2019, trading 425,531 units of MGTX stock currently worth $9,999,979.

What does MeiraGTx Plc do?

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

What does MeiraGTx Plc’s logo look like?

MeiraGTx Plc executives and stock owners

MeiraGTx Plc executives and other stock owners filed with the SEC include:

  • Alexandria Forbes, President, Chief Executive Officer, Director
  • Richard Giroux, Chief Financial Officer, Chief Operating Officer
  • Stuart Naylor, Chief Development Officer
  • Gregory Moss, Independent Director
  • Neil Mendoza, Independent Director
  • Joel Marcus, Independent Director
  • Arnold Levine, Independent Director
  • Martin Indyk, Director
  • Ellen Hukkelhoven, Independent Director
  • Thomas Shenk, Director
  • Nicole Seligman, Director
  • Keith Harris, Independent Chairman of the Board
  • Advisors Llcperceptive Life…,
  • Katherine Breedis, Chief Financial Officer
  • Life Sciences Master Fund L…,
  • Bruce Gottlieb, General Counsel
  • Advisors Llcedelman Joseph …,